Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. - Wikidata - wikimedia - TriplyDB

Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer.

Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer.

http://www.wikidata.org/entity/Q43983613

about

Hemoglobin level significantly impacts the tumor cell survival fraction in humans after internal radiotherapy.NEOadjuvant therapy monitoring with PET and CT in Esophageal Cancer (NEOPEC-trial).Current strategies in chemoradiation for esophageal cancer.Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma.Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma.Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer Early response evaluation and prediction in neoadjuvant-treated patients with esophageal cancer.Relationship between the Temporal Changes in Positron-Emission-Tomography-Imaging-Based Textural Features and Pathologic Response and Survival in Esophageal Cancer Patients.Imaging strategies in the management of oesophageal cancer: what's the role of MRI?A nomogram that predicts pathologic complete response to neoadjuvant chemoradiation also predicts survival outcomes after definitive chemoradiation for esophageal cancer.From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.Predicting response to treatment in gastroesophageal junction adenocarcinomas: combining clinical, imaging, and molecular biomarkers.The role of PET and PET-CT scanning in assessing response to neoadjuvant therapy in esophageal carcinoma Should preoperative, post-chemoradiotherapy endoscopy be routine for esophageal cancer patients?18F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making.Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol.Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation.Tumor SUVmax Normalized to Liver Uptake on (18)F-FDG PET/CT Predicts the Pathologic Complete Response After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer.PET/CT and hepatic radiation injury in esophageal cancer patients.18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients.Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer.Role of positron emission tomography in the (re-)staging of oesophageal cancer.(18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response.An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET.Oesophageal cancer: assessment of response and follow up The role of positron emission tomography in esophageal cancer.The 100 most cited articles investigating the radiological staging of oesophageal and junctional cancer: a bibliometric analysis.Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer.Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer.Esophageal cancer: current and emerging therapy modalities.Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction.Role of barium esophagography in patients with locally advanced esophageal cancer: evaluation of response to neoadjuvant chemoradiotherapy.PET imaging for Treatment Response in Cancer Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancer.Preoperative T Staging of Potentially Resectable Esophageal Cancer: A Comparison between Free-Breathing Radial VIBE and Breath-Hold Cartesian VIBE, with Histopathological Correlation Identification of Metabolic Biomarkers Using Serial 18F-FDG PET/CT for Prediction of Recurrence in Advanced Epithelial Ovarian Cancer Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy.Prognostic significance of SUV on PET/CT in patients with localised oesophagogastric junction cancer receiving neoadjuvant chemotherapy/chemoradiation:a systematic review and meta-analysis.Adjuvant therapy in esophagogastric adenocarcinoma: controversies and consensus.

P2860

Q30524018-B5265DD0-465E-4D15-83BC-D26B4D1B2A8C Q33356751-8A0E36DF-2603-4895-8FB7-5D7EE9CC31A7 Q33820782-FA9DBE7B-D7E6-4AC4-A346-C13EAE21A642 Q33866015-6B82E313-5959-41FC-B3A0-4C292A7FCC35 Q34104159-84568E24-96DF-472A-A863-1475A5571A4C Q34164634-B8B60C8E-8714-46A8-A879-2CEA863F9BFA Q34390923-0312E316-63B8-4CA1-8D7E-29AF0977A0B2 Q34521659-C8A41486-3A06-4540-85AA-69461C3CAD7C Q34583617-E1FFE08F-890A-4D82-97D6-FB6CCBBA2031 Q34961992-6A0F25C0-3293-4F52-892A-5F2AC2504990 Q34978457-8F69352B-18D2-4344-88C3-57634F246D3E Q35583933-F30F6044-6C85-4D8C-B6EE-5818CB53F574 Q35769322-C1833FF6-4C73-4D64-893C-1D3A41FA864A Q35824736-3D77179D-9D48-4CC8-A7F0-C8C07C7EA7D3 Q35830542-9542CF4E-AD0E-4E45-8479-E64CC85A0737 Q35922472-0E6E7161-82E5-405E-9147-EE2596139524 Q36022348-3512A3A3-96A5-4FEF-AE78-32060BEB6472 Q36064592-7441513D-F0F9-4EC6-A8D7-73703029E553 Q36278127-273A944D-12C3-4978-A7BD-DF7E90A159CA Q36295210-EF3B5D60-925D-4E34-BADF-2158527B5851 Q36328330-974F9A15-5128-42C6-88F6-ECA08CA47BAC Q36427789-CE5EB3CE-DAAF-401C-9CDF-02749136FD7A Q36510702-86188F58-2D58-45A3-A39B-D95739ECC61F Q36611842-32F68BC4-0882-4656-93C4-B62669F285BF Q36643836-06F19077-CB2A-4FE7-A2C7-70AE16C8A13D Q36963796-3FD6A60F-6733-427B-85FB-EC4B2FBF87B5 Q37072481-67D9DE87-02A5-4022-B593-F8C293BE5FDF Q37116282-65FA92F8-0C4F-4B68-9FB9-F21055528B30 Q37121648-F7F457AA-C435-4C7E-924B-96010C024539 Q37154079-0D88F761-AFB2-489D-BE09-63479823DBEC Q37256825-08681EC7-74ED-4C7C-8DFC-E1CF3520A02E Q37338260-D11E61FC-2508-45CE-A866-4BC74522A29D Q37402817-CE60CAE6-5CE2-4B32-B540-719C066118DA Q37465205-413DD83B-CF0D-4F9F-8FD8-71C337221276 Q37681293-24769810-05D8-420D-8116-309C997219FF Q37712152-7939A137-3566-490E-BA00-46FBD3D89EAF Q37715868-81637F29-1679-4C4A-AC56-5EAFDA0002F1 Q37717566-7D681BB2-D258-42F5-9640-234A66E958A2 Q37984273-01680681-9EE3-4A70-9A3F-F1BF7EA654BA Q38034225-8AED8E6F-697E-476A-9B0A-C1BEAA95E20F

P2860

Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer.

http://www.wikidata.org/entity/Q43983613

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Positron emission tomography f ...... y advanced oesophageal cancer.

@en

Positron emission tomography f ...... y advanced oesophageal cancer.

@nl

type

label

Positron emission tomography f ...... y advanced oesophageal cancer.

@en

Positron emission tomography f ...... y advanced oesophageal cancer.

@nl

prefLabel

Positron emission tomography f ...... y advanced oesophageal cancer.

@en

Positron emission tomography f ...... y advanced oesophageal cancer.

@nl

P1433

Q43983613-9BE4F544-3639-442E-871A-A0314137AF7E

P1476

Q43983613-C154E3FA-F1CB-4259-A48B-DE8F0A5BDF17

P2093

Q43983613-022A12C0-5EF8-42BB-8369-A3AB90834BD1

Q43983613-0446A13C-C144-4F78-B973-FD238669E1BF

Q43983613-0D93C8C1-91E9-4970-A135-65E952EE8001

Q43983613-1B45E762-587E-479B-92E8-531B2AC9BDE6

Q43983613-2B81700C-75FA-4E49-8BDD-EA75BF517733

Q43983613-3F837C5F-A1FA-4749-825D-20EB6C7F9849

Q43983613-728CB677-5D2B-4067-997A-0C785B5568B1

Q43983613-86179EF6-A948-4722-A2B4-C1E8C33EDEE4

Q43983613-D9B5B824-AC2E-49C2-BA52-D197EA5C829C

Q43983613-DFC8EF50-5435-482B-A853-5E8D679FCF77

P304

Q43983613-59C3DCF2-6849-4419-88FF-825918EB0501

P31

Q43983613-5349DAAF-420D-4FD9-ABD1-804B851F82D7

P356

Q43983613-20DE4B60-F8E2-4E45-883C-81BAAB992154

P433

Q43983613-4434544A-3D90-4F49-A091-0689E96977D4

P478

Q43983613-6F3FAAED-C8DB-42E4-81BC-B0A9D6E306DC

P577

Q43983613-7E3534B7-DB48-4116-AE2D-E97E10C6944A

P698

Q43983613-6B67F8A1-9CE9-4B3B-AE5F-CA77B98D8128

P921

Q43983613-0D1E7A16-CF83-4D12-8CC9-A218D800CED0

P356

P1433

Annals of Oncology

P1476

Positron emission tomography f ...... y advanced oesophageal cancer.

@en

P2093

A Lerut

http://www.w3.org/2001/XMLSchema#string

A Maes

http://www.w3.org/2001/XMLSchema#string

D Van Raemdonck

http://www.w3.org/2001/XMLSchema#string

E Van Cutsem

http://www.w3.org/2001/XMLSchema#string

G Bormans

http://www.w3.org/2001/XMLSchema#string

J P Cambier

http://www.w3.org/2001/XMLSchema#string

K Haustermans

http://www.w3.org/2001/XMLSchema#string

L Mortelmans

http://www.w3.org/2001/XMLSchema#string

N Ectors

http://www.w3.org/2001/XMLSchema#string

P De Leyn

http://www.w3.org/2001/XMLSchema#string

P304

361-368

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDF081

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11996465

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy